Search Results 1981-1990 of 19637 for hemoglobin

1. Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma - Mayo Clinic

   Hemoglobin (Hb) ≥ 8 g/dL;; Platelets (PLT) ≥ 75 × 10^9 /L or ≥ 50 × 10^9 /L in case of documented bone marrow involvement (> 50% or tumor cells), without ...

2. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Patients may be transfused to meet this criterion;; INR or aPTT ≤ 1.5 x upper limit of normal (ULN). This applies only to patients ...

3. A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

   Hemoglobin < 8 g/dL;; Platelets < 100,000/µL. Positive serum pregnancy test at the Screening visit or positive urine pregnancy test at the Baseline visit. No ...

4. Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma - Mayo Clinic

   Hemoglobin* ≥ 9 g/dL; Platelets** ≥ 100 000/mm^3 (≥ 100 × 10^9 /L); ANC*** ≥ 1000/mm^3 (≥ 1.0 × 10^9 /L). Hematologic function (Coagulation Factors). INR ...

5. A Study to Evaluate Pemetrexed and Pembrolizumab to Treat Recurrent and/or Metastatic Salivary Gland Malignancies - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; NOTE: Must be met without growth factor support and no transfusions < 14 days prior to testing; Absolute neutrophil count (ANC) ...

6. A Global, Randomized, Placebo-controlled Phase 3 Study of Fruquintinib in Patients with Refractory Metastatic Colorectal Cancer - Mayo Clinic

   Hemoglobin < 9.0 g/dL. Blood transfusion within 1 week prior to enrollment for the purpose of increasing the likelihood of eligibility is not allowed. Serum ...

7. Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary - Mayo Clinic

   Hemoglobin (Hgb) ≥ 8.5 g/dL without transfusion or EPO dependency (≤ 7 days prior to assessment); Platelets ≥ 90,000 / mcL; Creatinine OR Calculated ...

8. Neurology - Clinical trials - Mayo Clinic

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

9. A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy - Mayo Clinic

   Hematology. Platelets ≤ 75 × 109/L; Hemoglobin ≤ 9 g/dL; ANC ≤ 1.5 × 109/L. Hepatic. ALT > 2.5 × ULN OR > 5 × ULN for participants with liver metastases; AST ...

10. Diabetes Clinical Trials - Mayo Clinic Research

    ... Hemoglobin A1c La Crosse, WI ... Retrospective chart review will also be done to assess objective diabetic control based on most recent hemoglobin A1c.